pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·22h ago·1 min read
save

SCRS unveils Eagle Insights Dashboard to benchmark clinical trial site performance

Oct 20, 2026·read at Fierce Biotech ↗Positive

The Society for Clinical Research Sites introduced a new data intelligence platform called the Eagle Insights Dashboard. The tool provides sponsors and contract research organizations with a composite score that reflects how sites perform across several key areas, including study start-up, business development, contract language, communication, patient population representation, and technology.

By aggregating these ratings, the dashboard enables users to spot engagement gaps early, compare performance with peers, and make data-driven decisions about investments and processes. SCRS says the insights can help strengthen site relationships and foster a more collaborative environment within the clinical trial community.

The platform will incorporate data from 2025 and 2026 by November, allowing trend analysis over time. A leading global biopharmaceutical company has already adopted the dashboard as part of its commitment to improve site collaborations.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Advocacy organization launches data dashboard to better assess how clinical trial sites perform”

read at Fierce Biotech ↗
310 words · retrieved 21m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 23h agoRapport's phase 2 bipolar win strikes chord with analysts despite falling short of original ambitionFierce Biotech
  • 1d agoLycia aims for $228M IPO to generate data on food allergy rival to XolairFierce Biotech
  • 1d agoIndustry at a ‘turning point’ with growth dominated by commercial leaders: EY reportFierce Biotech
  • 1d agoPfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertainFierce Biotech
  • 1d agoAstraZeneca taps Oracle to help improve recruitment for clinical trialsFierce Biotech